boosting Oncology exploration with Integrated KRAS Assay products and services and RAS Assays
during the fast evolving field of oncology research, exact and productive mutation screening is essential for developing specific therapies. The KRAS products and services Platform performs a pivotal part During this landscape by presenting in depth remedies for KRAS mutation profiling and Evaluation. KRAS mutations, present in around 95% of RAS-li